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Abstract:
Background:
The presence of keratinized tissue around dental implants is more than desirable either from a functional and aesthetic point of view,
making soft  tissue grafting a  common practice in  implant  rehabilitation.  Autogenous soft  tissue grafting procedures are  usually
associated with high morbidity. Aim of this study was to assess the efficacy of a xenogeneic collagen matrix as a substitute for soft
tissue grafting around dental implants.
Methods:
15 consecutive patients underwent a vestibuloplasty and grafting, both in the mandible and the maxilla, with a collagen matrix.
Results:
The primary endpoint was to evaluate the resorption of the graft along with the re-epithelization grafted area. The percentage of the
resorption was 44,4%, with a mean gain in vestibular height of 3 mm. Secondary endpoints evaluated the clinical appearance, the
hemostatic effect and the post-operative pain. All subjects referred minimal pain with no bleeding. No adverse reaction nor infection
were noted.
Conclusion:
This study showed that the used collagen matrix can find major interest in those patients who need a greater aesthetic outcome as the
matrix has a perfect integration with the surrounding tissues. Furthermore it is strongly recommended for those patients who can bear
little pain.
Clinical Significance:
Post-operative morbidity  of  autologous grafts  is  the  biggest  concern of  this  type of  surgery.  The possibility  to  use  a  soft  tissue
substitute is a great achievement as morbidity decreases and bigger areas can be treated in a single surgery.
The present study showed the efficacy of a collagen matrix as this kind of substitute.
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INTRODUCTION
For  decades  mucogingival  surgery  has  been  common  practice  in  periodontology,  with  the  precise  endpoint  to
optimize the amount of keratinized soft tissues surrounding the natural teeth.
Keratinized gingiva (KG) is a specialized mucosa covered with keratin or parakeratin that includes the free and the
attached gingiva and extends from the gingival margin to the mucogingival junction [1].
The presence of a certain width of keratinized tissue is important in maintaining periodontal health and preventing
soft tissue recessions. A number of studies suggest that a minimum of 2 mm of KG, corresponding to 1 mm of attached
tissue, is necessary for a sustainable periodontal health [2]. The presence of this specialized mucosa appears to facilitate
plaque control, improving patient comfort and prevent gingival recession [3, 4].
As well as natural teeth, the presence of keratinized tissue is more than desirable around dental implants, especially
in the aesthetic zone.
Connective tissue grafts represent a reliable technique to supplement the thickness of
peri-implant soft tissues. Both free gingival and connective tissue grafts are however associated with significant
patient morbidity due to the need for a donor palate site, that leaves the periosteum exposed after surgery [3].
Unfortunately, high morbidity is common in al types of surgeries where autologous grafts are involved (like bone
grafting techniques), while xenogeneic materials do not present such inconvenience [4].
In order to avoid the morbidity associated with the donor site, an acellular dermal matrix (ADM), derived from
human cadaver, started to be used as a tissue substitute [5 - 7]. An alternative to allodermal matrices was found in the
use of collagen membranes of porcine origin [8, 9]. Despite of the presence in the current literature of many studies
reporting various attempts to augment the oral soft tissues using different materials, no ideal materials are currently
reported as available and, overall, predictable [10].
Theoretically and ideal non autologous graft for soft tissue substitution should promote haemostasis, be infection
resistant, favour the formation of granulation tissue, have a low post-operative morbidity and have a fast healing time.
Promoting  haemostasis  and  favouring  the  formation  of  granulation  tissue  are  two  critical  steps  of  the  healing
process. The micro architecture of the xenogeneic graft will be of particular importance for blood clot organization, as
shown  in  other  studies  where  absorbable  collagen  sponges  where  used  and  different  tissues  (such  as  bone)  where
involved [11 - 13]. At the same time, a correct resorption time of the grafting material will easily influence granulation
tissue and promote better healing, just like emblazoned bone reconstruction techniques [14].
Aim  of  the  present  study  was  to  evaluate  the  efficacy  of  a  xenogenic  collagen  matrix  (Geistlich  Mucograft®,
Geistlich Pharma AG, Wolhusen, CH), to increase soft tissue, used in a free gingival-like graft procedure.
MATERIALS AND METHODS
A multicentered (Milan University – School of Dentistry/Loma Linda University – School of Dentistry) clinical
study has been conducted on patients presenting areas of deficient attached and unattached mucosa and/or deficient
vestibular depth precluding the construction of effective functioning prosthesis. The study included a total of 15 patients
who  were  candidates  for  mucosal  soft  tissue  augmentation  or  lateral-medial  mucosal  extension  by  means  of  a
xenogeneic  collagen  matrix  (Geistlich  Mucograft®,  Geistlich  Pharma  AG,  Wolhusen,  CH).
The  xenogeneic  collagen  matrix(Mucograft®)  is  a  class  III  medical  device  according  to  the  Medical  Device
Directive 93/42 (EEC definitions: 1.1: longterm implant; 1.2: implantable; 8: resorbable and 17: porcine origin). Its
structure consists of two functional layers: a cell occlusive layer consisting of collagen fibers in a compact arrangement
and a thick porous layer. This porous layer provides a space that favors the formation of a blood clot and the ingrowth
of  tissue  from  adjacent  sites  (Fig.  1c).  This  xenogenic  graft  has  been  cleared  by  the  EU  and  US  Food  and  Drug
Administration for regenerative therapy involving teeth and implants.
The purpose of the surgery was to improve the quantity of attached and unattached mucosa in order to facilitate the
final prosthetic rehabilitation. The entire study was reviewed and approved by the Ethics Committee of the IRCCS
Ospedale Maggiore Policlinico di Milano, Fondazione Ca’ Granda.
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Primary Endpoints
The  primary  efficacy  parameters  to  be  considered  were  the  degree  of  lateral  and/or  alveolar  extension  and  the
evaluation of re-epithelization and shrinkage of the grafted area.
Secondary Endpoints
The secondary efficacy parameters included: haemostatic effect, pain evaluation, medication used to control pain
and discomfort and clinical evaluation of the grafted site.
Study Duration
The duration of the present study was 1 year following implantation of Geistlich Mucograft® for each study subject.
Number and Type of Subjects
Subjects were recruited from existing subject databases as well as from screenings performed at the department of
Dental Implants, Dental Clinic Fondazione Ca’ Granda, School of Dentistry, University of Milan and the department of
Orall and Maxillofacial Surgery, School of Dentistry, Loma Linda University Medical Center. A total of 15 subjects,
candidates for fixed mucosal soft tissue augmentation or a lateral extension of the edentulous alveolar ridge, had been
recruited for the study.
Inclusion Criteria
Subjects have read, understood and signed an approved Informed Consent Form.1.
Subjects  are  able  and  willing  to  follow  study  procedures  and  instructions,  including  exercising  good  oral2.
hygiene.
Subjects are 18 years or older.3.
Subjects  are  candidates  for  fixed  mucosal  soft  tissue  augmentation  or  an  extension  of  the  lateral  alveolar4.
mucosal ridge.
Subjects, if of child-bearing potential, must have a negative pregnancy test (validated OTC test) within 72 hours5.
prior to surgery and agree to use adequate contraception for at least 4 months after surgery.
Subjects agree to be financially responsible for the prosthodontics restoration of the surgical site.6.
Exclusion Criteria
Subjects have participated within the last six months in other clinical studies.1.
Subjects have failed to maintain good plaque control at the time of the screening appointment.2.
Subjects with any systemic condition including but not necessarily limited to:3.
Uncontrolled diabetes mellitus, cancer, HIV, disorders that compromise wound healing,
Diseases which affect bone or connective tissue metabolism, radiation or other immuno-
Suppressive therapy which would tend to compromise mucosal surgery.
Subjects with significant moderate to severe periodontal  disease (>Grade III),  caries,  or any active intraoral4.
infection.
Subjects do not agree to avoid using any nicotine-containing products within 2 weeks prior to surgery and 85.
weeks after surgery (including, but not limited to, smoking and chewing tobacco, nicotine patch, nicotine gum).
Subjects are nursing.6.
Subjects  taking  medications  or  having  treatment  which  may  have  an  effect  on  bone  turnover  and  mucosal7.
healing in general including, but not limited to:
Calcitonin within the last six months
Chronic tetracycline or tetracycline analogs, e.g. ongoing within the last month
Chronic steroids, e.g. cumulative dose of 150 mg of prednisone or equivalent within the last 6 months.
Biphosphonates or fluorides, at bone therapeutics levels, for at least 6 months prior to surgery.
Vitamin D and Vitamin D metabolites at therapeutic levels for 30 days or more within the last 6 months.
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Subject Withdrawal Criteria
Subjects were to be discontinued from the study prematurely if:
The subject required a different treatment;
The subject was non-compliant with the study protocol;
An adverse event occurred, whether or not Study Device related, which precluded continued treatment;
The subject requested to be withdrawn from the study;
The subject developed an exclusion criteria;
The Principal Investigator decided that it was in the subject’s best interest.
If a subject withdrawed from the study at any time, either at his request or at the Principal Investigator’s discretion,
the reason(s) for withdrawal were recorded by the Principal Investigator on the relevant page of the Case Report Form
(CRF). All final visit tasks were completed for all subjects who withdrawn from the study. Subjects withdrawn due to
related AEs were to be monitored until the adverse event had been solved or stabilized.
Objectives of the Surgery
The surgical procedure for this part of the study involved augmentation of attached mucosa and/or extension of the
mucosal  surface  in  edentulous  patients  and  in  partially  edentulous  patients  who  were  being  prepared  for  implant
supported reconstruction. The purpose of the surgery was to improve the quantity of keratinized mucosa in order to
facilitate the final dental reconstruction.
A secondary purpose for the surgery was to remove muscular and fibrous attachments which are located in adverse
positions occlusally at the alveolar-vestibular interface. A standard mucosal augmentation procedure, which is well-
reported  in  the  literature,  was  undertaken [15].  The  surgical  site  produced by the  surgery  leaved a  “denuded area”
supraperiosteally  which  was  addressed  by  “grafting”  with  a  xenogeneic  collagen  matrix  (Geistlich  Mucograft®,
Geistlich  Pharma  AG,  6110  Wolhusen,  CH).
Surgical Procedure
The procedure was performed in areas in which an occlusal augmentation or a lateral mucosal extension of crestal
soft  tissue  was  needed.  A  longitudinal  incision  was  performed  in  the  residual  keratinized  band,  extending  to  the
periosteum overlying the bone. This supra periosteal incision was carried posteriorly and anteriorly to the extent of the
desired  vestibular  deepening.  Any  muscle  fibers  and  fibrous  banding  attached  in  the  area  were  dissected  from the
periosteum and were reduced toward the depth of the vestibule. In addition, submucosal fatty tissue was also dissected
from the periosteum over the bone in the area.
The alveolar extension of the incision was made just into the area of the attached mucosa of the lateral alveolar
ridge. The lateral portion of the mucosal flap was sutured to the periosteum in the depth of vestibule. The denuded area
of the wound in the vestibule was then covered by the Geistlich Mucograft®. The Geistlich Mucograft® was sutured to
the surrounding mucosa anteriorly, posteriorly and in the vestibular direction (inferior in the case of the mandible and
superiorly in the case on the maxilla). The suturing was by 5-0 nylon. Approximately half of these sutures were allowed
to remain in place for a period of 4 to 6 weeks to determine the outline of the original periphery of the incision and
“graft” post-operatively. This was important in determining the area of actual re-epithelization of the defect, and in
determining and quantifying any shrinkage by scarring in the grafted area.
A previously prepared acrylic  splint  was placed over  the vestibuloplasty site  at  the time of  surgery.  This  splint
remained  in  place  for  10  days  at  which  time  it  was  removed.  The  patient  had  to  irrigate  the  area  with  0.9% NaCl
solution directly for the remaining portion of the study. The entire procedure has been described in literature [15].
Criteria for Evaluation
All examiners were blinded as to the patients smoking status, claims and discomfort, amount of pain medication
consumed, initial bleeding scores or any other measurable parameter.
Examiners were calibrated to ensure consistency by standard intraexaminer calibration techniques. A Kappa score
of at least 90% was required.
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Determination of Specific End Points
The patients  were seen 3 and 10 days after  surgery as  well  as  2,  3,  4  and 8,  weeks,  6  months and 1 year  post-
operatively.  Additionally,  patients  were  seen  at  any  time  during  the  course  of  the  clinical  evaluation.  Outcome
assessments are as follows.
Evaluation of Degree of Lateral and/or Alveolar Extension
To evaluate the extent of the post-surgical extension of the vestibule by the Geistlich Mucograft® procedure, a pre-
surgical impression was obtained under minimal pressure (a duplication system which allows for minimal distraction of
the pre-existing vestibule). Models made from this impression were used for two purposes:
For the construction of a splint to retain the test material graft. This splint was allowed to remain in place for 101.
days.
For  a  pre-operative  indication  of  the  mandibular  sulcular  depth.  The  mandibular  depth  was  measured  in2.
millimeters at approximately 3 to 5 points depending on the length of area that was reconstructed (usually one
mesially, one distally and 1 to 3 in between). This method has been previously reported in the literature [16].
The different steps were photographically documented.
Evaluation of Re-epithelization and Contraction of the Grafted Area
The  Geistlich  Mucograft®  was  sutured  to  the  surrounding  mucosa  by  5-0  monofilament  nylon.  The  size  of  the
regenerated  area  and  the  degree  of  scarring  which  might  reduce  the  area  was  determined  by  leaving  half  of  the
monofilament nylon sutures in place for a period of 3-4 weeks. The sutures served as a marker for measurement of the
regenerated area.
In all patients, the depth of the vestibule was recorded by probing at 3 to 5 points.
Measurements were taken at each post-op visit. The non-distended grafted area was measured at the time of surgery
through the center of the graft from peripheral sutures to the opposite peripheral side. Photographs were taken.
Hemostatic Effect
Bleeding  and  the  hemostatic  effect  of  the  Geistlich  Mucograft®  collagen  matrix  were  assessed  on  the  basis  of
applying a numerical scale to the surgical site as follows:
No active remarkable bleeding during the procedure, no post-operatively bleeding and normal post-operative1.
hemostatic course.
Slight bleeding at the graft margins at the completion of the procedure, but no bleeding post operatively. No2.
additional bleeding experienced by the patient post-operatively.
Post-operative hematoma or bleeding at the graft margins or beneath the graft surface at any post-operative time.3.
The condition is controllable by pressure means.
Intraoperative bleeding and immediate bleeding post-operatively. This refers to haemorrhage that is controlled4.
by surgical means, but determined to be greater than normal.
Pain Evaluation & Pain Relief
The  Mankoski  Pain  Scale  [17]  was  used  to  determine  and  to  record  the  discomfort  degree  experienced  by  the
patient. Pain was assessed at each post-operative visit as indicated previously or whenever the patient experienced an
incident of increased discomfort. The patient had to be seen on call at any time and the pain evaluated and appropriately
treated.
Medication Used to Control Pain & Discomfort
Medication for discomfort was based on the above cited Mankoski Scale. No medication would be necessary for
0-3,  for  4-5  mild  analgesics  (ASA,  acetaminophen  ibuprofen)  may  be  needed.  For  6-7  it  would  require  stronger
medication (e.g. synthetic hydrocodones).
#8-9 would necessitate increased use of narcotics including codeine and some additional medication of the order of
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triplicate prescription drugs. The latter would be a reportable incident event.
Lenght of Surgery
Operative time was recorded starting at the first incision and finishing with the last suture.
Clinical Evaluation of the Grafted Site
Evaluation of the grafted site was done by means of digital photographs taken at the indicated post-operative visits
of Day 3, Day 10, and at 2 weeks, 3 weeks, 4 weeks, 8 weeks, and 12 weeks. These photographs indicated the texture of
the  regenerated  area,  the  color  of  the  regenerated  tissue  and  the  extent  of  the  regenerated  clinically-apparent  new
mucosa (Figs. 1a-1f) [15].
Fig. (1a). Pre-op.
Fig. (1b). Post-op.
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Fig. (1c). 2 weeks after surgery.
Fig. (1d). 4 weeks after surgery.
Fig. (1e). 6 months after surgery.
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Fig. (1f). 1 year after surgery.
Statistical Significance
Since this study involved the acceptance of all patients who satisfied the inclusion and exclusion criteria, it was
difficult to determine an exact number of patients that would produce significance of the derived data. Since a split-
mouth design was not feasible and the defects being corrected by the mucosa particularly in the vestibular portion of the
study are not usually symmetrical or bilateral, the use of paired subjects was not a reliable format.
However, the data accumulated by the study would have been similar to that reported in the literature in evaluation
of materials of this type and the data as indicated above should have had clinical application [18].
It appeared that an appropriate number of patients for the proposed study was approximately 15.
Table 1. Criteria for evaluation.
Scoring Description
Epithelization 4-6 weeks post-op:
Excellent Entire wound
Good Greater than 80% of the entire wound
Fair 40-80% of the entire wound
Poor 10-40% of the entire wound
Lack of contracture 1 year post-op:
Excellent Little or none (less than 20% of grafted area)
Good Slight (less than 50%)
Fair to Poor Serious (50% or more)
Unsatisfactory Graft lost – Marked contraction
RESULTS
The collected data are based on the analysis of the 15 patients enrolled for the study, each of them were subject to
mucosal augmentation by means of a xenogeneic collagen matrix (Geistlich Mucograft®)
Aim of the study was to evaluate the efficacy of a xenogeneic collagen matrix as a substitute of soft tissue quality
optimization in implantology.
A total of 15 patients were enrolled for the study, 12 females and 3 males, aged between 43-72 years old. Of these
patients, 11 received surgery in the mandible and 4 in the maxilla.
At  1  year  2  patients  dropped  out  of  the  study:  patient  n°111  experienced  a  perimplantitis  that  required  a
conventional  free  gingival  graft  procedure  while  patient  n°113  developed  peri-implant  pockets  with  perimucositis,
making the 1 year analysis possible only on 13 patients. No allergic reactions were registered during the clinical trial.
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All the data were analyzed with IBM’s SPSS Statistics using ANOVA Repeated Measurements statistical method.
Contraction of the Grafted Area
The  following  results  were  obtained  by  calculating  the  average  loss  in  height  at  6  months  and  1  year  after  the
surgery. All the measurements of this primary endpoint are shown in Table 2.
Table 2. Probing depths at each post-operative visit (from mesial to distal).
Pz Pre-op Post-op 3 days 10 days 2 weeks 3 weeks 4 weeks 8 weeks 6 months 1 year
 mm mm mm mm mm mm mm mm mm mm
101 3, 2, 2 10, 8, 8 9, 7, 6 8, 6, 6 8, 6, 6 8, 6, 6 7, 6, 6 7, 6, 6 7, 6, 6 7, 6, 6
102 5, 0, 0 8, 6, 5 7, 6, 5 7, 5, 5 7, 4, 4 7, 4, 4 7, 4, 3 7, 3, 2 7, 3, 2 6, 2, 2
103 3, 2, 2 8, 9, 9 8, 8, 8 8, 8, 8 8, 7, 7 7, 6, 7 7, 6, 6 6, 6, 5.5 6, 6, 5 6, 5, 5
104 8, 6, 5, 5 15, 15, 10, 10 15, 15, 9, 10 12, 9, 9, 8 12, 9, 9, 8 12, 8, 8, 7 12, 9, 9, 8 12, 9, 8, 7 12, 9, 8, 7 10, 8, 8, 6
105 3, 3, 2, 2 10, 10, 6, 6 10, 10, 6, 6 n.d 9, 8, 6, 6 9, 8, 6, 5 9, 8, 6, 5 9, 8, 6, 5 9, 8, 6, 5 8, 8, 6, 5
106 8, 10, 10, 10 8, 11, 11, 11 8, 9, 9, 9 8, 9, 9, 9 8, 9, 9, 9 8, 9, 8, 8 8, 9, 8, 8 8, 9, 8, 8 8, 9, 8, 8 8, 9, 8, 8
107 2, 3, 3, 3 9, 10, 10, 10 9, 10, 10, 10 9, 10, 10, 10 9, 10, 10, 10, 9, 10, 10, 10 9, 10, 10, 10, 9, 10, 10, 10 8, 10, 10, 10 7, 9, 9, 9
108 3, 3, 3 11, 10, 10 11, 10, 10 11, 9, 10 11, 9, 10 11, 9, 10 11, 9, 10 10, 8, 9 10, 8, 9 8, 7, 8
109 2, 5, 5, 7 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 10 2, 7, 5, 9
110 3, 3, 0 5, 10, 10 5, 9, 9 5, 8, 8 5, 8, 8 5, 7, 7 5, 7, 7 5, 6, 6 5, 6, 6 5, 6, 5
111 8, 5, 3, 3, 2 8, 12, 10, 10, 9 8, 8, 6, 6, 6 8, 7, 6, 5, 4 8, 7, 6, 5, 2 8, 7, 6, 5, 2 8, 7, 6, 5, 2 8, 7, 6, 5 8, 6, 6, 5, 2 n.d
112 15, 10, 7, 5 15, 15, 12, 10
15, 13, 10,
10 15, 13, 10,10 15, 13, 10, 10 15, 12, 10, 10 15, 12, 12, 10 15, 12, 12, 10 15, 12, 12, 10
15, 12, 10,
9
113 6, 3, 3, 2 6, 9, 9, 8 6, 6, 6, 5 6, 6, 6, 5 6, 6, 6, 5 7, 6, 6, 5 6, 6, 6, 5 6, 6, 6, 5 6, 6, 6, 5 n.d
114 7, 5, 3, 3 12, 10, 10, 8 12, 10, 10, 8 12, 10, 10, 8 12, 10, 10, 8 12, 10, 9, 7 12, 10, 9, 7 11, 10, 8, 7 10, 10, 7, 7 9, 8, 6, 6
115 9, 5, 3, 5 9, 9, 7, 9 9, 9, 7, 7 9, 9, 7, 7 9, 9, 7, 7 9, 9, 7, 7 9, 9, 7, 7 8, 8, 7, 6 7, 7, 6, 6 7, 7, 6, 6
The average size of the grafted matrix was 8 mm in height per 22 mm in length.
The vestibular probing depth (PD) was measured in millimeters at approximately 3 to 5 five points depending on the
length of the area that was grafted.
Pre-operative and post-operative probing mean values were 4,1mm and 9,4mm respectively, corresponding to an
initial mean gain of 5,3mm.
The probing mean value at 6 months after surgery was 7,3mm, resulting in 2,1mm mean loss in height.
After 1 year from the surgery the probing mean value was 7mm, indicating an additional 0,3mm loss. (Tables 3 and
4; Fig. 2).
This data indicates a 39,5% contraction of the vestibular area at 6 months, while it goes up to 44,4% after 1 year.
Table 3. Descriptive statistics.
Mean measures Variable Standard deviation N
Pre-op (mm) 4,1 2,3 15
Post-op (mm) 9,4 1,62 15
6 months (mm) 7,3 2,03 15
1 year (mm) 7 1,76 13
There are differences between the values recorded from the maxilla and the mandible: vestibular PD in the mandible
showed 31% and 42% shrinkage versus 42% and 54% in the maxilla, at 6 months and 1 year respectively.
Considering each single value can be helpful to see the distribution of these results.
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Fig. (2). Changes over time in vestibular PD.
Referring to the Table 1 of evaluation reported previously, it can be said that at 6 months the degree of shrinkage in
height is Fig. (3a):
Fig. (3a). Shrinkage at 6 months.
-excellent in 29,4% of the single measurements
-good in 39,2%
-fair in 19,6%
-unsatisfactory in 11,8%
The values change at 1 (Fig. 3b) year, showing:
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Fig. (3b). Shrinkage at 1 year.
-excellent in 15,9% of the single measurements
-good in 38,6%
-fair in 33,1%
-unsatisfactory in 11,4%
Clinically, it  was assessed that the height of the keratinized tissue was never lower than the adjacent sites, thus
confirming that the height of keratinized tissue is genetically pre-determined.
Table 4. Degree of shrinkage and percentages per single patient.
Pz Pre-op (mm) Post-op (mm) 6 months (mm) 6 months shrinkage 1 year (mm) 1 year shrinkage
101 2.3 8.7 6.3 37% 6.3 37%
102 1.7 6.3 4 50% 3.3 64%
103 2.3 8.7 5.7 48% 5.3 53%
104 6 12.5 9 54% 8 69%
105 2.5 8 7 18% 6.8 23%
106 9.5 10.3 8.3 100% 8.3 100%
107 2.8 9.8 9.5 4% 8.5 18%
108 3 10.3 9 18% 7.7 46%
109 6 8.5 8.5 0% 8 20%
110 2 8.3 5.7 42% 5.3 47%
111 3.3 10.3 4.8 79% / /
112 7.3 12.3 11.3 20% 10.3 40%
113 2.7 8.7 5.7 50% / /
114 4.5 10 8.5 27% 7.3 50%
115 5.5 8.5 6.5 67% 6.5 67%
Evaluation of Re-epithelization
For what concerns re-epithelization, it was clinically shown that healing was completed after 4 weeks in 11 patients
(evaluated  as  excellent),  80%  in  2  patients  (evaluated  as  good)  and  between  40-80%  in  the  remaining  2  subjects
(evaluated  as  fair).  After  8  weeks  healing  was  completed  in  all  patients.  Digital  pictures  were  taken  at  each  post-
operative visit as indicated by the protocol (Fig. 4).
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Fig. (4). Healing evaluation: re-epithelization at 4 weeks.
Hemostatic Effect
Other information can be found from the analysis of the data concerning the secondary endpoints. According to the
post-operative experience described by the patients themselves, the bleeding score was 1, comparable to non-bleeding.
Bleeding scores were registered during surgery and at the first two post-op follow-ups (3 days and 10 days after
surgery), with the method reported previously in the “Materials and Methods” section.
Pain Evaluation
13 patients referred absolutely no pain after surgery, comparable with a Mankoski’s scale grade 1, while 2 patients
took a mild analgesic (NSAID) after the surgery (comparable with a grade 3) (Fig. 5). The Mankoski pain scale has
been previously discussed in the “Materials and Methods” section. Pain was registered until it was clinically assessed
that healing of the grafted site was completed.
Fig. (5). Pain evaluation: grades in Mankoski’s pain scale.
DISCUSSION
The  study  was  carried  out  to  evaluate  the  efficacy  of  a  xenogeneic  collagen  matrix  when  used  as  a  soft  tissue
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substitute in the reconstruction of an adequate amount (at least 2 mm) of keratinized tissue around dental implants. In
particular,  shrinkage,  re-epithelization,  hemostatic  effect,  post-operative  morbidity  and  the  aesthetic  outcome  were
evaluated.
The collected data can be partially compared with the results of other studies found in literature for what concerns
the use of non-autologous grafting techniques.
One of the first studies was conducted by Schoo and Coppes, who experimented the capacities of a freeze-dried dura
mater grafting material (different from today’s ADMs) in stimulating keratinized mucosa, with very poor results [19].
Two studies by Harris, in 2001, analyzed the usefulness of ADMs when positioned upon periosteum [20] and bone
[21], without any particular results.
Furthermore  in  2001  Wei  P.  and  Laurell  L.  conducted  two  studies:  one  clinical  and  the  other  histological.  12
patients were enrolled for these studies, 6 of whom received an autologous graft while the remaining an allogeneic one.
The increment in adherent mucosa was detectable in both groups, but the gain was very little with the allogeneic graft.
This was due to an excessive shrinkage of the graft post-operatively.
Histologically it was shown that all grafted sites presented a tissue very similar to scar tissue, incapable of inducing
cellular differentiation.
One of the biggest concerns about this material was the fast resorption [22, 23], leading to a disturbed healing.
As a connective tissue graft, acellular matrices are epitheliazed by proliferation of the surrounding tissue. The only
way to obtain keratinized tissue is to put in contact the margins of the graft with the host’s keratinized mucosa [4].
Subsequent studies obtained better results.
The  same Harris  underlined  the  efficacy  of  ADMs as  a  substitute  in  soft  tissue  grafting,  pointing  out  the  great
aesthetic outcome [24].
Other  authors  (Lee  KH,  Kim  BO  et  al.)  demonstrated  how  these  matrices  show  statistically  significant  and
comparable results confronted with the most emblazoned autologous grafting techniques, evaluating keratinized mucosa
augmentation, gain in thickness, plaque index, bleeding on probing and vestibular depth [25].
These results were all confirmed by a further histological study [26]. During the first week of healing they noticed a
tissue remodelling due to phagocytosis of pre-existing collagen fibers by macrophages. At week 2, new collagen fibers
were detected as long as neoangiogenesis and re-epithelization on the membrane surface. At 4 weeks it was difficult to
find pre-existing collagen fibers. At 10 weeks the healing process was complete and the aestethic outcome good.
A  study  by  Sanz  M  and  coworkers  confirmed  how  xenogeneic  collagen  matrices  guarantee  predictable  and
satisfactory results. In particular, for this study, a porcine derived collagen matrix was used. The primary endpoint was
to evaluate the potentiality in gaining keratinized tissue in comparison with an autologous graft. At 6 months (end of
study) the collected data was perfectly comparable, showing an insignificant statistical variance between the two grafts
(60% shrinkage for the autologous and 67% for the xenogeneic) [27].
Nevins M. et al. had the same results evaluating the porcine collagen matrix around a single tooth. At 12 months
from surgery, both grafts (xenogeneic and autologous) had a perfect healing, with mature connective tissue and the
presence of a nice keratinized mucosa. The author itself wanted to underline better aestethic outcome of the collagen
matrix, showing a perfect tissue integration [28].
Similar outcomes were found by Schmitt CM, Tudor C et al. in their study, which compared free gingival grafts and
a porcine collagen matrix (Geistlich Mucograft®). At 90 days after surgery biopsies were harvested for histologic and
immunohistologic analisys showing the presence of specific keratinized tissue markers in the collagen matrix grafted
areas. Furthermore, secondary endpoints concerned length of surgery, post-op morbidity and clinical appearance with
results comparable to the ones obtained in the present study [29].
The  data  collected  in  the  present  study  can  be  perfectly  compared  with  the  data  from other  studies  and  can  be
considered satisfactory for what concerns the set endpoints.
At 6 months the majority of the results falls between the interval considered as excellent or good, while at 1 year
there is balance between excellent/good results and fair ones.
Analyzing the post-operative course, from all the aforementioned studies, one factor is particularly highlighted: the
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great decrease in morbidity.
Post-operative pain in autologous grafting is due to the second surgical site, the donor site.
The majority of patients who underwent this type surgery didn’t feel any pain at all, except a little nuisance that
required a mild analgesic as medication.
It has to be said that this material is extremely easy to use, with an average length of surgery of 30 minutes (time
took from the first incision to the last suture), also confirmed by literature [27].
About intra-operative and post-operative bleeding, the xenogeneic collagen matrix showed a nice hemostatic effect
with no excessive bleeding during surgery and no bleeding at all during post-operative course, comparable to the use of
absorbable collagen sponges in different kind of treatments, like bisphosphonate related necrosis of the jaw surgeries or
reconstructions after tumor resection [30, 31].
Furthermore, all grafted sites presented, when healing was completed, an optimal integration with the surrounding
tissues, as stated by other authors in previous studies [27 - 29].
A precise time of surgery, in particular second stage surgery or re-entry, could help achieving the best results, as
suggested by a literature review on vestibuloplasty techniques by Bassetti et al. [32]. Unfortunately studies involving
only an apically repositioned split thickness flap are very limited, but it has been shown that this technique is more
effective in the maxilla, where a bigger reservoir of keratinized mucosa is present [32].
Wider experience and more studies on the comparison between adding a xenogeneic graft or not should be pursued
for the future.
CONCLUSION
The  analysis  of  the  data  establishes  that  the  collagen  matrix  satisfies  entirely  the  primary  and  the  secondary
endpoints of this study.
The percentage of shrinkage of the graft is not high, as shown in the evaluation criteria.
The collagen matrix integration is slow and constant, providing the necessary scaffold to regenerate keratinized
mucosa and ensuring a perfect healing.
No bleeding was reported by the patients and post-operative morbidity was very low.
At the simple observation of the grafted areas it is possible to notice the high aesthetic outcome. No “patch-work”
effect nor dischromia with the surrounding tissue was observed. This is due to the migration of epithelial cells on the
surface of the collagen matrix, which does not happen with autologous grafts, who maintain their own epithelium.
This study shows that this type of collagen matrix (Geistlich Mucograft®) can find major interest in those patients
who need a keratinized tissue augmentation around implants with great aesthetic outcome or that can bear little pain.
It is well known that a sample of 15 patients cannot be considered statistical significant and for this reason further
studies will be necessary to assess definitively the efficacy and the applications of this material, eventually gaining
statistical value [33].
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